Keli Walbert

Director, Apellis Pharmaceuticals, Inc.

Companies

Hemab Therapeutics Holdings, Inc.Board member Sep 25, 2026 to now¹
SPRUCE BIOSCIENCES, INC.Board member Dec 15, 2025 to now²
Apellis Pharmaceuticals, Inc.Board member Jan 10, 2025 to now³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Apellis Pharmaceuticals, Inc.0 shares⁴May 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

May 14, 2026Returned to company 7,297 shares of Apellis Pharmaceuticals, Inc.⁴
May 14, 2026Returned to company 664 shares of Apellis Pharmaceuticals, Inc.⁴
May 14, 2026Returned to company 8,332 shares of Apellis Pharmaceuticals, Inc.⁴
May 14, 2026U 17,051 shares of Apellis Pharmaceuticals, Inc.⁴
Jan 1, 2026Granted 7,961 shares of Apellis Pharmaceuticals, Inc.⁵
Jan 8, 2025Granted 9,090 shares of Apellis Pharmaceuticals, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARHemab Therapeutics Holdings, Inc., Board member
2
SEC EDGARSPRUCE BIOSCIENCES, INC., Board member
3
SEC EDGARApellis Pharmaceuticals, Inc., Board member
4
SEC EDGARApellis Pharmaceuticals, Inc. shares after the filing of May 14, 2026
5
SEC EDGARForm 4 filed Jan 5, 2026
6
SEC EDGARForm 4 filed Jan 10, 2025